Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
0.7851
-0.1548 (-16.47%)
At close: Oct 31, 2025, 4:00 PM EDT
0.7655
-0.0196 (-2.50%)
After-hours: Oct 31, 2025, 7:59 PM EDT
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of $8.33 million as of October 31, 2025. Its market cap has decreased by -25.68% in one year.
Market Cap
8.33M
Enterprise Value
2.36M
1-Year Change
-25.68%
Ranking
Category
Stock Price
$0.79
Market Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from $4.97M to $8.33M, an increase of 67.65%. That is a compound annual growth rate of 4.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 8.33M | -24.75% |
| Dec 31, 2024 | 11.07M | -48.88% |
| Dec 31, 2023 | 21.67M | -19.15% |
| Dec 29, 2022 | 26.80M | -60.87% |
| Dec 30, 2021 | 68.47M | 2.08% |
| Dec 31, 2020 | 67.08M | 364.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 756.15B |
| Johnson & Johnson | 455.48B |
| AbbVie | 403.13B |
| UnitedHealth Group | 312.23B |
| AstraZeneca | 255.76B |
| Novartis AG | 236.67B |
| Novo Nordisk | 222.08B |
| Abbott Laboratories | 216.79B |